Coloplast Ownership

CBHD Stock  EUR 65.64  1.40  2.18%   
Coloplast holds a total of 207.37 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2018-06-30
Previous Quarter
225 M
Current Value
225 M
Avarage Shares Outstanding
214.7 M
Quarterly Volatility
5.3 M
 
Covid
 
Interest Hikes
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.

Coloplast Stock Ownership Analysis

About 30.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.26. Coloplast AS last dividend was issued on the 5th of December 2025. The entity had 5:1 split on the 19th of December 2012. Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany. For more info on Coloplast AS please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.

Coloplast Outstanding Bonds

Coloplast issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Coloplast Stock

Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.